iShares US Pharmaceuticals ETF
IHE
IHE
93 hedge funds and large institutions have $60.9M invested in iShares US Pharmaceuticals ETF in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 32 reducing their positions, and 11 closing their positions.
Holders
93
Holders Change
-2
Holders Change %
-2.11%
% of All Funds
2.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
22
Reduced
32
Closed
11
Calls
$1.14M
Puts
$800K
Net Calls
+$344K
Net Calls Change
+$693K
Top Buyers
Top Sellers
1 |
1
Goldman Sachs
New York
|
$315K |
2 |
2
Fisher Asset Management
Camas,
Washington
|
$1.63M |
3 |
3
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$3.53M |
4 |
4
Citadel Advisors
Miami,
Florida
|
$3.37M |
5 |
5
Bank of America
Charlotte,
North Carolina
|
$3.19M |